International Journal of Laboratory Hematology

Article	Citations
COVID‐19 and the clinical hematology laboratory	174
Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2	113
Absolute lymphocyte count is a prognostic marker in Covid‐19: A retrospective cohort review	71
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia	65
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2	57
Evaluation of COVID‐19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays	54
Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis	49
COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces	48
Standardization of Prothrombin Time/International Normalized Ratio (PT/INR)	47
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19	42
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID‐19 outbreak: Letter from the warfront…	40
A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity	40
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy	40
COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations	35
LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR‐155	34
The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays	33
Machine learning in health care and laboratory medicine: General overview of supervised learning and Auto‐ML	31
COVID‐19–related laboratory coagulation findings	28
SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19	27
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13	25
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients	24
Clinical and hematological characteristics of 88 patients with COVID‐19	24
Testing for antiphospholipid antibodies: Advances and best practices	24
Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit	24
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing	23

Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID‐19 infection	23
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory	22
Lymphopenia in critically ill COVID‐19 patients: A predictor factor of severity and mortality	21
Age‐ and sex‐specific pediatric reference intervals for neutrophil‐to‐lymphocyte ratio, lymphocyte‐to‐monocyte ratio, and platelet‐to‐lymphocyte ratio	21
Relationship of D‐dimer with severity and mortality in SARS‐CoV‐2 patients : A meta‐analysis	21
Peripheral blood morphologic findings in patients with COVID‐19	21
A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine	21
Higher coagulation activity in hip fracture patients: A case‐control study using rotational thromboelastometry	20
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting	20
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID‐19 patients: Retrospective analysis	20
Monocyte volumetric parameters and lymph index are increased in SARS‐CoV‐2 infection	20
Neutrophil‐to‐lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID‐19	19
Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples	19
Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process	19
International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing	19
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions	19
Evaluation of Scopio Labs X100 Full Field PBS: The first high‐resolution full field viewing of peripheral blood specimens combined with artificial intelligence‐based morphological analysis	18
Plasmablastic lymphoma: An update	18
The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐19	18
Clinical assessment of the utility of metagenomic next‐generation sequencing in pediatric patients of hematology department	18
COVID‐19 in patients with hematological malignancies: A retrospective case series	18
Kinetics of immune reconstitution after anti‐CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients	17
Procoagulant platelets: Laboratory detection and clinical significance	17
Gene therapy for hemophilia: Current status and laboratory consequences	16
How I investigate neutropenia	15
Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection	15
Diagnosis and treatment of thrombotic microangiopathy	15
Thrombosis and antiphospholipid antibodies in patients with SARS‐COV‐2 infection (COVID‐19)	14
Interest of the cellular population data analysis as an aid in the early diagnosis of SARS‐CoV‐2 infection	14
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma	14
Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa	13
Complex biological patterns of hematology parameters in childhood necessitating age‐ and sex‐specific reference intervals for evidence‐based clinical interpretation	13
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood	13
Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway	13
Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm	13
The hemoglobinopathies, molecular disease mechanisms and diagnostics	13
The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review	12
COVID‐19 and the ABO blood group in pregnancy: A tale of two multiethnic cities	12
Peripheral lymphocyte subset alterations in COVID‐19 patients	12
P‐glycoprotein and multidrug resistance‐associated protein‐1 expression in acute myeloid leukemia: Biological and prognosis implications	12
Lupus anticoagulant in patients with COVID‐19	12
Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐19	12
Significance of RDW in predicting mortality in COVID‐19—An analysis of 622 cases	11
Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation	11
Performance evaluation of the new hematology analyzer UniCel DxH 900	11
How I investigate acquired megaloblastic anemia	11
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab	11
Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in NPM1‐mutated acute myeloid leukemia	11
International Council for Standardization in Haematology (ICSH) laboratory guidance for the verification of haemostasis analyser‐reagent test systems. Part 2: Specialist tests and calibrated assays	11
Flow cytometry in the diagnosis of mature B‐cell lymphoproliferative disorders	11

Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban	11
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M‐hemoglobin variants	11
Analysis of hematological indexes of COVID‐19 patients from fever clinics in Suzhou, China	11
Changes in peripheral blood cellular morphology as diagnostic markers for COVID‐19 infection	10
Update on platelet procoagulant mechanisms in health and in bleeding disorders	10
Is neutrophilia associated with mortality in COVID‐19 patients? A meta‐analysis and meta‐regression	10
Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants	10
Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay	10
Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study	10
Monocyte distribution width adds prognostic value in detection of COVID‐19 respiratory failure	10
Recurrent PROC and novel PROS1 mutations in Vietnamese patients diagnosed with idiopathic deep venous thrombosis	10
Are the DOAC plasma level thresholds appropriate for clinical decision‐making? A reappraisal using thrombin generation testing	10
Evolving concepts of pathogenesis of heparin‐induced thrombocytopenia: Diagnostic and therapeutic implications	10
Laboratory approach to investigation of anemia in pregnancy	9
Identification of acquired PIGA mutations and additional variants by next‐generation sequencing in paroxysmal nocturnal hemoglobinuria	9
Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis	9
Overall hemostasis potential and aPTT‐clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype	9
A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network	9
ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies	9
International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser‐reagent test systems. Part 1: Instrument‐specific issues and commonly use	9
Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera	9
Trimester‐specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state	9
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD—Comparison of four assay methods	9
Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications	9
Diagnostic value of white blood cell parameters for COVID‐19: Is there a role for HFLC and IG?	9
Increased monocyte distribution width in COVID‐19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency	9
TACC3 expression as a prognostic factor in aggressive types of adult T‐cell leukemia/lymphoma patients	9
Plasma hemoglobin: A method comparison of six assays for hemoglobin and hemolysis index measurement	9
Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays	8
COVID‐19 patient with immune thrombocytopenic purpura	8
New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data	8
Major rise of a chronic lymphoid leukemia clone during the course of COVID‐19	8
Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia	8
Circulating tumor DNA by high‐throughput sequencing of T cell receptor monitored treatment response and predicted treatment failure in T cell lymphomas	8
Cell population data: Could a routine hematology analyzer aid in the differential diagnosis of COVID‐19?	8
Identification of thalassemia gene cluster deletion by long‐read whole‐genome sequencing (LR‐WGS)	8
Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat	8
Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine	8
Effects of circadian variation, lifestyle and environment on hematological parameters: A narrative review	8
Study of in vitro thrombin generation after neutralization of heparin	8
The characteristic peripheral blood morphological features of hospitalized patients infected with COVID‐19	8
The effect of DOAC‐Stop® on several oral and parenteral anticoagulants	8
Harmonizing platelet function analyzer testing and reporting in a large laboratory network	8
Reduced activity of B lymphocytes, recognised by Sysmex XN‐2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019	8
To B‐ or not to B‐: A review of lineage switched acute leukemia	8
Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed	8
Systematic review about etiologic association to the leukoerythroblastic reaction	8
Evaluation of the accuracy of immature granulocyte percentage in predicting pediatric serious bacterial infection	8
Standardization and harmonization in hematology: Instrument alignment, quality control materials, and commutability issue	7
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐19	7
Pneumatic tube transport of blood samples affects global hemostasis and platelet function assays	7
The integration of Sysmex XN‐9100’ WPC channel reflex testing in the detection of reactive versus malignant blood samples	7
Application of an optimized interpretation model in capillary hemoglobin electrophoresis for newborn thalassemia screening	7
The lncRNA SLCO4A1‐AS1/miR‐876‐3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway	7
Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunity	7
Detection and significance of green inclusions in peripheral blood neutrophils and monocytes	7
Predicting bacteraemia in maternity patients using full blood count parameters: A supervised machine learning algorithm approach	7
Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients	7
Usefulness of automated fragmented red blood cell percentage in the diagnosis of paediatric haemolytic uraemic syndrome	7
Thrombin generation abnormalities in Quebec platelet disorder	7
Laboratory methods for monitoring argatroban in heparin‐induced thrombocytopenia	7
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges	7
How I investigate minimal residual disease in acute lymphoblastic leukemia	7
CXCL2 benefits acute myeloid leukemia cells in hypoxia	7
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy	7
Screening on platelet LncRNA expression profile discloses novel residual platelet reactivity biomarker	7
Development and exacerbation of autoimmune hemolytic anemia following COVID‐19 vaccination: A systematic review	7
Erythropoiesis changes with increasing age in the elderly Chinese	7
Immune thrombocytopenic purpura after COVID‐19 infection	7
Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method	7
Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience	7
Distinguishing iron deficiency from beta‐thalassemia trait by new generation ektacytometry	7
Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study	7
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months	7
Spectrum mutations of PRF1, UNC13D, STX11, and STXBP2 genes in Vietnamese patients with hemophagocytic lymphohistiocytosis	6
Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID‐19—A common clinical feature between a rare disorder and a new, common infection	6
Neutrophil‐to‐lymphocyte ratio is independently associated with COVID‐19 severity: An updated meta‐analysis based on adjusted effect estimates	6
Parameters of the complete blood count predict in hospital mortality	6
Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera	6
Transient increase in blast count following COVID‐19 infection mimicking acute leukemia	6

Continuous reference curves for common hematology markers in the CALIPER cohort of healthy children and adolescents on the Sysmex XN‐3000 system	6
Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants	6
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations	6
Thrombin generation abnormalities in commonly encountered platelet function disorders	6
Aiding clinical assessment of neonatal sepsis using hematological analyzer data with machine learning techniques	6
Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia	6
CaMKIIγ regulates the viability and self‐renewal of acute myeloid leukaemia stem‐like cells by the Alox5/NF‐κB pathway	6
Use of Sysmex XN‐10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia	6
Evaluation of a new thromboplastin reagent STA‐NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels	6
High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID‐19 diagnosis?	6
Downregulation of Lymphoid enhancer‐binding factor 1 (LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologi	6
Impact of variation in reagent combinations for one‐stage clotting assay on assay discrepancy in nonsevere haemophilia A	6
Rebuttal of a paper submitted by Hans‐Inge Bengtsson	6
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID‐19	6
A study to compare Hematopoietic Progenitor Cell count determined on a next‐generation automated cell counter with flow cytometric CD34 count in peripheral blood and the harvested peripheral blood ste	6
Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum	6
Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia	6
High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic synd	6
Laboratory practices for manual blood film review: Results of an IQMH patterns of practice survey	6
Do congenital bleeding disorders have a protective effect against COVID‐19? A prospective study	6
Cross‐evaluation of five slidemakers and three automated image analysis systems: The pitfalls of automation?	6
Association of FOXP3 gene polymorphisms with chronic immune thrombocytopenia in a Chinese Han population	6
Pitfalls in CALR exon 9 mutation detection: A single‐center experience in 571 positive patients	6
Brief communication: Distribution of bone marrow cell subsets and hemodilution in patients with acute leukemia	6
Biological variation data and analytical specification goal estimates of the thrombin generation assay with and without thrombomodulin in healthy individuals	5
PCAT18, as a novel differentially regulated long noncoding RNA in adult acute myeloid leukemia patients revealed by next‐generation sequencing	5
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients	5
Reference intervals of white blood cell parameters for healthy adults in japan	5
Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment	5
Evaluation and comparison of the new Mindray BC‐6200 hematology analyzer with ADVIA 2120i	5
Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer	5
Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis	5
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing	5
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltra	5
Evaluation of automated capillary complete blood counts for routine clinical decision making in a large cohort of hematological patients, using Mindray BC‐3000 Plus Auto and Sysmex XE‐5000 hematology	5
How I investigate dysgranulopoiesis	5
The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm	5
Circulating Hodgkin cells: A clinicopathologic analysis of seven patients and a review of the literature	5
A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease	5
Red cell distribution width and in‐hospital mortality in septic shock: A public database research	5
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia	5
Functional multigenic variations associated with hodgkin lymphoma	5
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X	5
Improvement of mortality prediction accuracy in critically ill patients through combination of SOFA and APACHE II score with markers of stress haematopoiesis	5
Differences between capillary and venous blood counts in children—A data mining approach	5
Early detection of Candida parapsilosis sepsis in peripheral blood as a result of cytografic changes on the Sysmex XN‐3000 hematology analyzer	5
Comparative sequencing data analysis of Ion Torrent and MinION sequencing platforms using a clinical diagnostic haematology panel	5
Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis	5
A new approach for diagnosing hematological malignancies using monocytosis workflow optimization and abnormal lymphocyte/blast flag of Sysmex XN series of blood count analyzers	5
IgE monoclonal gammopathy: The clinical relevance to perform the immunofixation using IgE antisera	5
C‐reactive protein‐induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII	5
Immature platelet fraction over time and clinical outcomes in patients with acute myocardial infarction	5
Platelet count in sodium citrate‐anticoagulated whole blood: Comparison to EDTA‐anticoagulated results and stability over time	5
Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study	5
Schistocyte quantitation, thrombotic microangiopathy and acute kidney injury in Australian snakebite coagulopathy [ASP28]	5
Limitations of a calibrated, quantitative APC‐R assay under routine conditions	5
Establishing Ghanaian adult reference intervals for hematological parameters controlling for latent anemia and inflammation	5
Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen	5
Full spectrum flow cytometry in the clinical laboratory	5
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia	5
Persistent hiccups in a patient with mild congenital factor V deficiency and COVID‐19; clinical and laboratory finding of a rare bleeding disorder	5
Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure	5
Automated differential diagnosis method for iron deficiency anemia and beta thalassemia trait based on iterative Chi2 feature selector	5
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates	5
Standardization of reticulocyte counts in the athlete biological passport: A practical update	5
Reduced expansion of CD94/NKG2C+ NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or	5
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials	5
Falsely decreased FVIII activity following pneumatic tube transport	4
MicroRNAs in urine as diagnostic biomarkers for multiple myeloma	4
Alterations in leucocyte cell population data in bacteraemia: A study from a tertiary care hospital in India	4
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors	4
Routine haematology parameters in COVID‐19 patients and clinical outcome: A Belgian single‐centre study	4
Characterization and identification of Prachinburi β0‐thalassemia: A novel‐60 kb deletion in beta globin gene related to high levels of Hb F in heterozygous state	4
Differential diagnosis of thalassemia and iron deficiency anemia using the CellaVision Advanced Red Blood Cell software	4
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform	4
Viscoelastic testing: Critical appraisal of new methodologies and current literature	4
Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+	4
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays	4
Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital	4
Epigenetic analysis reveals significant differential expression of miR‐378C and miR‐128‐2‐5p in a cohort of relapsed pediatric B‐acute lymphoblastic leukemia cases	4
Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods	4
A stepwise haematological screening and whole‐exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A2 from a cohort of 47336 indivi	4
Analysis of laboratory blood parameter results for patients diagnosed with COVID‐19, from all ethnic group populations: A single centre study	4
Reference intervals of automated reticulocyte count and immature reticulocyte fraction in a pediatric population	4
Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next‐Generation Sequencing are associated with disease progression in a North American Adult T‐Cell Leukemia/Lympho	4
The role of cystatin C in multiple myeloma	4
Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study	4
Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia	4
Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia	4
A comparative evaluation of the CN‐6000 haemostasis analyser using coagulation, amidolytic, immuno‐turbidometric and light transmission aggregometry assays	4
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing	4
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy	4
Applied machine learning in hematopathology	4
Improving performance of recently introduced flow cytometry‐based approach of malignant cell screening in serous cavity effusion	4
Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients	4